Nemolizumab

MedChem Express

Nemolizumab

10

Research Use Only

Monoclonal

99.70

Nemolizumab (CIM331) is a humanized monoclonal antibody that targets the human interleukin-31 receptor a, preventing interleukin-31 ( IL-31 ) from binding to its receptor and the subsequent signaling. Nemolizumab can help reduce itching and sleep disturbances, and it is being studied for atopic dermatitis (AD) [1] [2] .

-80°C

12352203